Dex-(KW)3

General Information


DRACP ID  DRACP00245

Peptide Name   Dex-(KW)3

Sequence  KWKWKW

Sequence Length  6

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
PC-3 Prostate carcinoma Carcinoma 60% viablity=10 µM MTT assay Not available 1
MCF-7 Invasive breast carcinoma of no special type Carcinoma 35-40% viablity=10 µM MTT assay Not available 1

Hemolytic Activity  rabbit red blood cell: hemolysis=1.9±0.2%

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00245

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C51H68N12O7

Absent amino acids  ACDEFGHILMNPQRSTVY

Common amino acids  KW

Mass  105054

Pl  11.1

Basic residues  3

Acidic residues  0

Hydrophobic residues  3

Net charge  3

Boman Index  -966

Hydrophobicity  -240

Aliphatic Index  0

Half Life 
  Mammalian: 1.2 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  16500

Absorbance 280nm  3300

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 20964334

Title  Synthesis, characterization, and thermodynamic study of a polyvalent lytic peptide-polymer conjugate as novel anticancer agent

Doi 10.1021/bc1002899

Year  2010

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.